# Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation

> **NCT01894035** · — · COMPLETED · sponsor: **Bayer** · enrollment: 13 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** Iloprost (Ventavis, BAYQ 6256)

## Key facts

- **NCT ID:** NCT01894035
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-23
- **Primary completion:** 2016-07-20
- **Final completion:** 2017-04-13
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2018-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01894035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01894035, "Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01894035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*